This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Ligand Pharmaceuticals, Inc.
Drug Names(s): LGD1550
Description: The nuclear receptors that mediate the effects of retinoids are the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs). LGD1550 is a novel synthetic RAR-selective retinoid.
Additional information available to subscribers only: